Cidara Therapeutics, Inc.

TWO SIGMA ADVISERS, LP

Report date

3/31/2024

Quarter

2024 Q1

Filed

5/15/2024

Shares

23,900

Value ($000)

22

Weight

0.0%

2019 Q4 - 2024 Q1 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2024 Q1	5/15/2024	22	0.0%	23,900	3/31/2024
2023 Q4	2/14/2024	32	0.0%	40,400	12/31/2023
2023 Q3	11/14/2023	52	0.0%	55,200	9/30/2023
2023 Q2	8/14/2023	87	0.0%	76,600	6/30/2023
2023 Q1	5/15/2023	81	0.0%	63,600	3/31/2023
2022 Q4	2/14/2023	20	0.0%	25,800	12/31/2022
2022 Q3	11/14/2022	18	0.0%	28,200	9/30/2022
2022 Q2	8/15/2022	19	0.0%	38,694	6/30/2022
2022 Q1	5/16/2022	129	0.0%	154,394	3/31/2022
2021 Q4	2/14/2022	694	0.0%	546,294	12/31/2021
2021 Q3	11/15/2021	1,050	0.0%	468,594	9/30/2021
2021 Q2	8/16/2021	82	0.0%	40,594	6/30/2021
2021 Q1	5/17/2021	236	0.0%	88,794	3/31/2021
2020 Q4	2/16/2021	69	0.0%	34,654	12/31/2020
2020 Q3	11/16/2020	146	0.0%	51,394	9/30/2020
2020 Q2	9/15/2020	323	0.0%	87,654	6/30/2020
2020 Q1	5/15/2020	91	0.0%	36,854	3/31/2020
2019 Q4	2/14/2020	54	0.0%	14,000	12/31/2019